Erratum: BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells(PLoS ONE(2014)9:5(e96733)10.1371/journal.pone.0096733);BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Kaza, Niroop ^a   Kohli, Latika ^a,b   Graham, Christopher D ^a   Klocke, Barbara J ^a   Carroll, Steven L ^a,c   Roth, Kevin A ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; ISOSORBIDE; PROTEIN BNIP3; ANTINEOPLASTIC AGENT; BNIP3 PROTEIN, HUMAN; GOSSYPOL; GOSSYPOL ACETIC ACID; HIF1A PROTEIN, HUMAN; IRON; MEMBRANE PROTEIN; ONCOPROTEIN;

ARTICLE; AUTOPHAGY; CANCER CELL; CELL DEATH; CELL VIABILITY; CONCENTRATION RESPONSE; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG MECHANISM; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; IN VITRO STUDY; IRON BINDING CAPACITY; IRON CHELATION; MALIGNANT PERIPHERAL NERVE SHEATH TUMOR; PROTEIN EXPRESSION; PROTEIN FUNCTION; ANALOGS AND DERIVATIVES; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; NEURILEMMOMA; PATHOLOGY; SCHWANN CELL; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; AUTOPHAGY; CELL DEATH; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; GOSSYPOL; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IRON; MEMBRANE PROTEINS; NEURILEMMOMA; PROTO-ONCOGENE PROTEINS; SCHWANN CELLS;

EID: 84901276827     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0137153     Document Type: Erratum

References (69)

1. Brossier NM, Carroll SL (2012) Genetically engineered mouse models shed new light on the pathogenesis of neurofibromatosis type I-related neoplasms of the peripheral nervous system. Brain Res Bull 88: 58-71.
2. King AA, Debaun MR, Riccardi VM, Gutmann DH (2000) Malignant peripheral nerve sheath +
3. Evans DG, Baser ME, McGaughran J, Sharif S, Howard E, et al. (2002) Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet 39: 311-314. (Pubitemid 34526349)
4. Ferner RE, Gutmann DH (2002) International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis. Cancer Res 62: 1573-1577. (Pubitemid 34407825)
5. Rasmussen SA, Friedman JM (2000) NF1 gene and neurofibromatosis 1. Am J Epidemiol 151: 33-40. (Pubitemid 30470392)
6. Hanahan D,Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
7. Adams JM, Cory S (2007) The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26: 1324-1337. (Pubitemid 46328466)
8. Placzek WJ, Wei J, Kitada S, Zhai D, Reed JC, et al. (2010) A survey of the antiapoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy. Cell Death Dis 1: e40.
9. Park HJ, Lee SJ, Sohn YB, Jin HS, Han JH, et al. (2013) NF1 deficiency causes Bcl-xL upregulation in Schwann cells derived from neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors. Int J Oncol 42: 657-666.
10. Lee SJ, Park HJ, Kim YH, Kim BY, Jin HS, et al. (2012) Inhibition of Bcl-xL by ABT-737 enhances chemotherapy sensitivity in neurofibromatosis type 1-associated malignant peripheral nerve sheath tumor cells. Int J Mol Med 30: 443-450.
11. Adams R, Geissman TA, Edwards JD (1960) Gossypol, a pigment of cottonseed. Chem Rev 60: 555-574.
12. Vermel EM, Krugliak SA (1963) Antineoplastic activity of gossypol in experimental transplanted tumors. Vopr Onkol 21: 39-43.
13. Vermel EM, Kruglyak SA (1965) Antitumor activity of gossypol in experiments on transplantable tumors. Fed Proc Transl Suppl 24: 106-108.
14. Kitada S, Leone M, Sareth S, Zhai D, Reed JC, et al. (2003) Discovery, characterization, and structure-activity relationships studies of proapoptotic polyphenols targeting B-cell lymphocyte/leukemia-2 proteins. J Med Chem 46: 4259-4264. (Pubitemid 37153007)
15. Kang MH, Reynolds CP (2009) Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy. Clin Cancer Res 15: 1126-1132.
16. Yu ZH, Chan HC (1998) Gossypol as a male antifertility agent-why studies should have been continued. Int J Androl 21: 2-7.
17. Waites GM, Wang C, Griffin PD (1998) Gossypol: reasons for its failure to be accepted as a safe, reversible male antifertility drug. Int J Androl 21: 8-12. (Pubitemid 28230974)
18. Reyes J, Borriero L, Benos DJ (1988) A bioenergetic model of gossypol action: effects of gossypol on adult rat spermatogenic cells. Am J Physiol 254: C564-570.
19. Wang Y, Rao PN (1984) Effect of gossypol on DNA synthesis and cell cycle progression of mammalian cells in vitro. Cancer Res 44: 35-38. (Pubitemid 14178057)
20. Jan CR, Lin MC, Chou KJ, Huang JK (2000) Novel effects of gossypol, a chemical contraceptive in man: mobilization of internal Ca(2+) and activation of external Ca(2+) entry in intact cells. Biochim Biophys Acta 1496: 270-276.
21. Nakadate T, Jeng AY, Blumberg PM (1988) Comparison of protein kinase C functional assays to clarify mechanisms of inhibitor action. Biochem Pharmacol 37: 1541-1545. (Pubitemid 18093348)
22. Wang Y, Lonard DM, Yu Y, Chow DC, Palzkill TG, et al. (2011) Small molecule inhibition of the steroid receptor coactivators, SRC-3 and SRC-1. Mol Endocrinol 25: 2041-2053.
23. Meng Y, Tang W, Dai Y, Wu X, Liu M, et al. (2008) Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa. Mol Cancer Ther 7: 2192-2202.
24. Voss V, Senft C, Lang V, Ronellenfitsch MW, Steinbach JP, et al. (2010) The pan-Bcl-2 inhibitor (-)-gossypol triggers autophagic cell death in malignant glioma. Mol Cancer Res 8: 1002-1016.
25. Stonecypher MS, Byer SJ, Grizzle WE, Carroll SL (2005) Activation of the neuregulin-1/ErbB signaling pathway promotes the proliferation of neoplastic Schwann cells in human malignant peripheral nerve sheath tumors. Oncogene 24: 5589-5605. (Pubitemid 43119353)
26. Geng Y, Kohli L, Klocke BJ, Roth KA (2010) Chloroquine-induced autophagic vacuole accumulation and cell death in glioma cells is p53 independent. Neuro Oncol 12: 473-481.
27. Walls KC, Ghosh AP, Franklin AV, Klocke BJ, Ballestas M, et al. (2010) Lysosome dysfunction triggers Atg7-dependent neural apoptosis. J Biol Chem 285: 10497-10507.
28. Jiang J, Slivova V, Jedinak A, Sliva D (2012) Gossypol inhibits growth, invasiveness, and angiogenesis in human prostate cancer cells by modulating NF-κB/AP-1 dependent- and independent-signaling. Clin Exp Metastasis 29: 165-178.
29. Hu W, Wang F, Tang J, Liu X, Yuan Z, et al. (2012) Proapoptotic protein Smac mediates apoptosis in cisplatin-resistant ovarian cancer cells when treated with the anti-tumor agent AT101. J Biol Chem 287: 68-80.
30. Lian J, Wu X, He F, Karnak D, Tang W, et al. (2011) A natural BH3 mimetic induces autophagy in apoptosis-resistant prostate cancer via modulating Bcl-2-Beclin1 interaction at endoplasmic reticulum. Cell Death Differ 18: 60-71.
31. Gao P, Bauvy C, Souquère S, Tonelli G, Liu L, et al. (2010) The Bcl-2 homology domain 3 mimetic gossypol induces both Beclin 1-dependent and Beclin 1-independent cytoprotective autophagy in cancer cells. J Biol Chem 285: 25570-25581.
32. Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, et al. (2000) LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 19: 5720-5728.
33. Klionsky DJ, Elazar Z, Seglen PO, Rubinsztein DC (2008) Does bafilomycin A1 block the fusion of autophagosomes with lysosomes? Autophagy 4: 849-950.
34. Seglen PO, Gordon PB (1982) 3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes. Proc Natl Acad Sci U S A 79: 1889-1892. (Pubitemid 12088533)
35. Blommaart EF, Krause U, Schellens JP, Vreeling-Sindelárová H, Meijer AJ (1997) The phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated rat hepatocytes. Eur J Biochem 243: 240-246. (Pubitemid 27060408)
36. Zhang J, Ney PA (2009) Role of BNIP3 and NIX in cell death, autophagy, and mitophagy. Cell Death Differ 16: 939-946.
37. Byun YJ, Kim SK, Kim YM, Chae GT, Jeong SW, et al. (2009) Hydrogen peroxide induces autophagic cell death in C6 glioma cells via BNIP3-mediated suppression of the mTOR pathway. Neurosci Lett 461: 131-135.
38. Zhang Z, Shi R, Weng J, Xu X, Li XM, et al. (2011) The proapoptotic member of the Bcl-2 family Bcl-2/E1B-19K-interacting protein 3 is a mediator of caspase-independent neuronal death in excitotoxicity. FEBS J 278: 134-142.
39. Walls KC, Ghosh AP, Ballestas ME, Klocke BJ, Roth KA (2009) bcl-2/Adenovirus E1B 19-kd interacting protein 3 (BNIP3) regulates hypoxia-induced neural precursor cell death. J Neuropathol Exp Neurol 68: 1326-1338.
40. Bruick RK (2000) Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc Natl Acad Sci U S A 97: 9082-9087.
41. Daido S, Kanzawa T, Yamamoto A, Takeuchi H, Kondo Y, et al. (2004) Pivotal role of the cell death factor BNIP3 in ceramide-induced autophagic cell death in malignant glioma cells. Cancer Res 64: 4286-4293. (Pubitemid 38802435)
42. Lee JW, Bae SH, Jeong JW, Kim SH, Kim KW (2004) Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions. Exp Mol Med 36: 1-12.
43. Kazi AA, Koos RD (2007) Estrogen-induced activation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor expression, and edema in the uterus are mediated by the phosphatidylinositol 3-kinase/Akt pathway. Endocrinology 148: 2363-2374. (Pubitemid 46997054)
44. Treins C, Giorgetti-Peraldi S, Murdaca J, Semenza GL, Van Obberghen E (2002) Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway. J Biol Chem 277: 27975-27981. (Pubitemid 34966746)
45. Zhong H, Chiles K, Feldser D, Laughner E, Hanrahan C, et al. (2000) Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res 60: 1541-1545. (Pubitemid 30183422)
46. Park SS, Bae I, Lee YJ (2008) Flavonoids-induced accumulation of hypoxia-inducible factor (HIF)-1alpha/2alpha is mediated through chelation of iron. J Cell Biochem 103: 1989-1998. (Pubitemid 351501927)
47. Triantafyllou A, Liakos P, Tsakalof A, Chachami G, Paraskeva E, et al. (2007) The flavonoid quercetin induces hypoxia-inducible factor-1alpha (HIF-1alpha) and inhibits cell proliferation by depleting intracellular iron. Free Radic Res 41: 342-356. (Pubitemid 46404478)
48. Daniels TR, Delgado T, Rodriguez JA, Helguera G, Penichet ML (2006) The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer. Clin Immunol 121: 144-158. (Pubitemid 44592578)
49. Zhang M, Liu H, Guo R, Ling Y, Wu X, et al. (2003) Molecular mechanism of gossypol-induced cell growth inhibition and cell death of HT-29 human colon carcinoma cells. Biochem Pharmacol 66: 93-103. (Pubitemid 36724903)
50. Oliver CL, Miranda MB, Shangary S, Land S, Wang S, et al. (2005) (-)-Gossypol acts directly on the mitochondria to overcome Bcl-2- and Bcl-X(L)-mediated apoptosis resistance. Mol Cancer Ther 4: 23-31. (Pubitemid 40268063)
51. Ready N, Karaseva NA, Orlov SV, Luft AV, Popovych O, et al. (2011) Double-blind, placebo-controlled, randomized phase 2 study of the proapoptotic agent AT-101 plus docetaxel, in second-line non-small cell lung cancer. J Thorac Oncol 6: 781-785.
52. Baggstrom MQ, Qi Y, Koczywas M, Argiris A, Johnson EA, et al. (2011) A phase II study of AT-101 (Gossypol) in chemotherapy-sensitive recurrent extensive-stage small cell lung cancer. J Thorac Oncol 6: 1757-1760.
53. Liu G, Kelly WK, Wilding G, Leopold L, Brill K, et al. (2009) An open-label, multicenter, phase I/II study of single-agent AT-101 in men with castrate-resistant prostate cancer. Clin Cancer Res 15: 3172-3176.
54. Heist RS, Fain J, Chinnasami B, Khan W, Molina JR, et al. (2010) Phase I/II study of AT-101 with topotecan in relapsed and refractory small cell lung cancer. J Thorac Oncol 5: 1637-1643.
55. Floridi A, D'Atri S, Menichini R, Marcante ML, Nista A, et al. (1983) The effect of the association of Gossypol and Lonidamine on the energy metabolism of Ehrlich ascites tumor cells. Exp Mol Pathol 38: 322-335. (Pubitemid 13074129)
56. Kim SH, Kim JH, Alfieri AA, He SQ, Young CW (1985) Gossypol, a hyperthermic sensitizer of HeLa cells. Cancer Res 45: 6338-6340. (Pubitemid 16224805)
57. Mego M (2002) Telomerase inhibitors in anticancer therapy: gossypol as a potential telomerase inhibitor. Bratisl Lek Listy 103: 378-381.
58. DeBonis S, Skoufias DA, Lebeau L, Lopez R, Robin G, et al. (2004) In vitro screening for inhibitors of the human mitotic kinesin Eg5 with antimitotic and antitumor activities. Mol Cancer Ther 3: 1079-1090. (Pubitemid 39295005)
59. Jiang J, Sugimoto Y, Liu S, Chang HL, Park KY, et al. (2004) The inhibitory effects of gossypol on human prostate cancer cells-PC3 are associated with transforming growth factor beta1 (TGFbeta1) signal transduction pathway. Anticancer Res 24: 91-100. (Pubitemid 38279693)
60. Ko CH, Shen SC, Yang LY, Lin CW, Chen YC (2007) Gossypol reduction of tumor growth through ROS-dependent mitochondria pathway in human colorectal carcinoma cells. Int J Cancer 121: 1670-1679. (Pubitemid 47417282)
61. Volate SR, Kawasaki BT, Hurt EM, Milner JA, Kim YS, et al. (2010) Gossypol induces apoptosis by activating p53 in prostate cancer cells and prostate tumor-initiating cells. Mol Cancer Ther 9: 461-470.
62. Moon DO, Kim MO, Lee JD, Kim GY (2008) Gossypol suppresses NF-kappaB activity and NF-kappaB-related gene expression in human leukemia U937 cells. Cancer Lett 264: 192-200.
63. Lei X, Chen Y, Du G, Yu W, Wang X, et al. (2006) Gossypol induces Bax/Bak-independent activation of apoptosis and cytochrome c release via a conformational change in Bcl-2. FASEB J 20: 2147-2149.
64. Lian J, Karnak D, Xu L (2010) The Bcl-2-Beclin 1 interaction in (-)-gossypol-induced autophagy versus apoptosis in prostate cancer cells. Autophagy 6: 1201-1203.
65. Gewirtz DA (2014) The Four Faces of Autophagy: Implications for Cancer Therapy. Cancer Res 74: 647-651.
66. Sikora MJ, Bauer JA, Verhaegen M, Belbin TJ, Prystowsky MB, et al. (2008) Anti-oxidant treatment enhances anti-tumor cytotoxicity of (-)-gossypol. Cancer Biol Ther 7: 767-776.
67. Walls KC, Ghosh AP, Ballestas ME, Klocke BJ, Roth KA (2009) bcl-2/Adenovirus E1B 19-kd interacting protein 3 (BNIP3) regulates hypoxia-induced neural precursor cell death. J Neuropathol Exp Neurol 68: 1326-1338.
68. Guo K, Searfoss G, Krolikowski D, Pagnoni M, Franks C, et al. (2001) Hypoxia induces the expression of the pro-apoptotic gene BNIP3. Cell Death Differ 8: 367-376. (Pubitemid 32409607)
69. Santos JE, Mena H, Huber JT, Tarazon M (2005) Effects of source of gossypol and supplemental iron on plasma gossypol in Holstein steers. J Dairy Sci 88: 3563-3574. (Pubitemid 41624083)